Payments Made. As of the Closing Date, Seller has received from each Counterparty (or its predecessor in interest), as applicable, the full amount of all Royalty Payments required to be made pursuant to the applicable Depomed Agreements. None of the Royalty Payments listed in the Royalty Reports were received by the Seller from the applicable Counterparty (or its predecessor in interest) more than ten (10) calendar days after the due date therefor.
Appears in 4 contracts
Samples: Royalty Purchase Agreement (Relief Therapeutics Holding SA), Royalty Purchase Agreement (Relief Therapeutics Holding SA), Royalty Purchase Agreement (Relief Therapeutics Holding SA)
Payments Made. As of the Closing Date, the Seller has Parties have received from each Counterparty (or its predecessor in interest), as applicable, the full amount of all Royalty Payments required to be made pursuant to the applicable Depomed Product Agreements. None Except as set forth on Exhibit C, none of the Royalty Payments listed in the Royalty Reports were received by the Seller from the applicable Counterparty (or its predecessor in interest) more than ten (10) calendar days after the due date therefor.
Appears in 1 contract
Samples: Royalty Purchase Agreement (EyePoint Pharmaceuticals, Inc.)
Payments Made. As of the Closing Date, Seller has received from each Counterparty (or its predecessor in interest), as applicable, the full amount of all Royalty Payments required to be made pursuant to the applicable Depomed Product Agreements. None Except as set forth on Exhibit C, none of the Royalty Payments listed in the Royalty Reports were received by the Seller from the applicable Counterparty (or its predecessor in interest) more than ten (10) calendar days after the due date therefor.
Appears in 1 contract
Samples: Royalty Purchase Agreement (IntelGenx Technologies Corp.)
